bio

The paper uses a panel of firms to explore the locational patterns and place-specific evolution of the in the U.S. biotech industry. The study adapts the concept of the anchor tenant from real estate economics to explore the locational concentration and specialization of the emerging biotech industry.

The ten year strategic plan is a document that represents the insights and opinions of industry, academic and government leaders and should serve as a catalyst for action that will harness the untapped potential of the LA region. The strategic plans guiding principles and specific recommendations are centered on four critical initiatives that are most important to the success of the Life Sciences in the region.

To promote biotech in Baton Rouge, the study sponsored by Capital Region Competitive Strategy recommends constructing an" idea pipeline" to better commercialize the intellectual property and research generated in the regions universities, hospitals and research institutes.

The report from the Office of Technology Policy provides a comprehensive and detailed look at the emerging U.S. biotech industry. The survey found respondents who are engaged in biotechnology research, development and applications reported in 2001 they had more than 1.1 million employees, total annual net sales of about $567 billion, operating income of $100.5 billion, capital expenditures of $29.5 billion, and R&D expenditures of $41.6 billion.

The report conducted by The Boston Consulting Group and the Massachusetts Biotechnology Council charts the potential benefit and risk impact of state action or inaction. The report argues that the Massachusetts industry could be responsible for creating as many as 150,000 new jobs by 2010 with one-third directly in the biotech industry.

Analyses, direction and recommended actions for three key sector areas-workforce, business and research development are provided in the statewide plan to develop biotechnology and life sciences industry sectors in Colorado. The plan outlines the states current strengths and identifies key factors for success.

The paper highlights meetings and interviews with government, research and development, and business executives that took place in Singapore in December 2001. The paper discuss the goals, strategy and programs of Singapore’s economic development “model” as applied to its biomedical initiative to describe the current biomedical sector, and to evaluate short and long-term implications for America’s biomedical industry.

The study covers the partnering activity of 25 dedicated biotechnology SMEs located within six clusters on the periphery of France. Specifically, the paper examines the relationship between clustering and long distance partnering from the perspective of evolutionary economics and the innovation systems literature.

The report published by the Institute for Emerging Issues at North Carolina State University concludes that biotechnology has enormous potential for North Carolinas future, but the states economic development strategy must be broader than any single industry and must include growth-from-within strategies. The report also calls attention to the dilemma of how to best capitalize on the concentration of biotechnology in the research triangle while addressing the need for statewide economic growth.

The report finds that Arizona possesses many of the essential elements needed to become a national leader in the biosciences. The authors contend that biosciences not only would build upon Arizonas strengths in electronics, optics and advanced engineering, but would also bring stability to the states economy.